Fast Track Initiative
2 rounds tracked since 15 April 2026.
- Rounds
- 2
- Led
- 0
- Capital in these rounds
- $74M
Sectors
Countries
Rounds
- STORM TherapeuticsDevelops RNA-modifying enzyme inhibitors for cancer, led by METTL3 inhibitor STC-15 $56MSeries C · 15 Apr
- Sonire TherapeuticsUltrasound-guided HIFU therapy system for treating pancreatic cancer $18MSeries A · 15 Apr
No round matches these filters.